Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept

Por Borsotto, M, Veyssiere, J, Moha ou Maati, H, Devader, C, Mazella, J, Heurteaux, C
Publicado no Br J Pharmacol (2015)

In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin

Por Devader, C, Khayachi, A, Veyssière, J, Moha ou Maati, H, Roulot, M, Moreno, S, Borsotto, M, Martin, S, Heurteaux, C, Mazella, J
Publicado no Br J Pharmacol (2015)

Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation

Por Etiévant, A., Oosterhof, C., Bétry, C., Abrial, E., Novo-Perez, M., Rovera, R., Scarna, H., Devader, C., Mazella, J., Wegener, G., Sánchez, C., Dkhissi-Benyahya, O., Gronfier, C., Coizet, V., Beaulieu, J.M., Blier, P., Lucas, G., Haddjeri, N.
Publicado no EBioMedicine (2015)